WEBINAR: Innovations in Food Allergy Treatment: What Healthcare Providers Need to Know

Monday, October 26, 2026, 2:00 p.m.–3:00 p.m. ET 

Advances in food allergy diagnosis and treatment are rapidly changing the standard of care. Join us on October 26 at 2 p.m. ET for a webinar featuring Dr. Sharon Chinthrajah, who will discuss the latest evidence on emerging therapies, evolving treatment strategies, and what these developments mean for clinical practice.

Designed for healthcare providers, this session will provide practical insights into patient-centered treatment options and approaches to shared decision-making that can help improve outcomes and quality of life for individuals living with food allergy. 

About the Speaker

R. Sharon Chinthrajah, MD 

R. Sharon Chinthrajah, MD is an Associate Professor and the Co-Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. Dr. Chinthrajah received her MD from Drexel University College of Medicine, completed her Internal Medicine training and a chief residency at California Pacific Medical Center, and sub-specialized in Pulmonary/Critical Care and Allergy/Immunology at Boston Medical Center. Her research is focused on developing novel therapeutic options for allergic diseases as well as unraveling the molecular mechanisms driving therapeutic response. She has extensive experience performing both academic and industry-sponsored clinical trials investigating allergic diseases such as food allergy, atopic dermatitis, eosinophilic esophagitis, asthma, and COVID-19. Her research has led to the publication of over 160 research articles in peer-reviewed journals, including studies that led to the FDA approval of omalizumab for the treatment of food allergy. She is dedicated to training the next generation of clinical researchers and continues to act as a mentor for students and junior faculty interested in pursuing medical research. 

This webinar is supported by Genentech, a Member of the Roche Group.